Revive Active for Menopausal Health Issues

This trial tests a health product called Revive Active Product 1 to determine its effectiveness in alleviating menopausal symptoms such as hot flashes. The study compares the effects of Revive Active against a placebo (a substance with no active ingredients) to assess its impact on menopause-related health outcomes. Women who are peri or post-menopausal and have experienced hot flashes for at least three months may qualify. Participants must live in the U.S. and be willing to remain unaware of whether they receive the actual product or the placebo during the study. As an unphased trial, this study provides a unique opportunity to contribute to research that could enhance menopausal health outcomes.

Yes, you may need to stop taking certain medications if they interact with the study product. Specifically, if you are taking medications like anticoagulants, antihypertensives, or others listed in the exclusion criteria, you might not be eligible to participate.

Previous studies have not identified major safety concerns for most people using Revive Active Product 1. However, individuals with heart, liver, or kidney problems might face serious risks with this product. For those without these health issues, the treatment is generally safe. Participants with these conditions should consult a healthcare provider before participating.¹²³⁴⁵

Most treatments for menopausal symptoms focus on hormone replacement or managing individual symptoms like hot flashes with medications such as antidepressants or gabapentin. However, Revive Active Product 1 is unique because it offers a non-hormonal approach that targets overall menopausal health. Researchers are particularly excited about its potential to improve multiple symptoms simultaneously, possibly due to its innovative formulation that might enhance energy levels and support cognitive function. This could offer a more holistic alternative to the current standard of care, which often requires multiple treatments to address different symptoms.

Research has shown that Revive Active Product 1, which participants in this trial may receive, may help alleviate menopause symptoms. In one study, 93% of users stopped experiencing hot flashes by day 60. Additionally, 88% reported reduced sweating, and 91% felt less anxious. Another study found that the treatment reduced tiredness by 57.7% in women. These findings suggest that Revive Active Product 1 could help manage various menopause-related issues.¹²³⁵⁶